Cargando…
Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial
BACKGROUND AND OBJECTIVE: Loxoprofen (LOX) is a nonsteroidal anti-inflammatory drug (NSAID). Although oral administration of LOX has been widely prescribed, clinical guidelines for osteoarthritis generally recommend topical rather than oral NSAIDs in specific patients. However, there is limited info...
Autores principales: | Zhao, Dongbao, Chen, Zhiwei, Hu, Shaoxian, Lin, Jianhao, Shao, Zengwu, Wang, Guochun, Xiao, Weiguo, Zheng, Yi, Zhang, Zhiyi, Shi, Yeqing, Li, Zhanguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443607/ https://www.ncbi.nlm.nih.gov/pubmed/30725315 http://dx.doi.org/10.1007/s40261-019-00756-x |
Ejemplares similares
-
Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label study
por: Fan, Meida, et al.
Publicado: (2019) -
Acute Interstitial Nephritis and Acute Tubular Injury Due to a Transdermal Loxoprofen Patch
por: Shinzato, Takahiro, et al.
Publicado: (2020) -
Loxoprofen: Drug eruption: case report
Publicado: (2020) -
Loxoprofen‐induced bullous fixed drug eruption
por: Yamada, Takayuki, et al.
Publicado: (2019) -
Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy
por: Araki, Hisazumi, et al.
Publicado: (2013)